MétaCan
Menu
Back to cohort
Record W4416789154 · doi:10.1186/s40814-025-01731-4

The SQUEEZE pilot trial: a trial to determine whether septic shock reversal is quicker in pediatric patients randomized to an early goal directed fluid-sparing strategy vs. usual care

2025· article· en· W4416789154 on OpenAlexafffund
Melissa Parker, Karen Choong, Alison Fox‐Robichaud, Patricia C. Liaw, Lehana Thabane

Bibliographic record

VenuePilot and Feasibility Studies · 2025
Typearticle
Languageen
FieldMedicine
TopicSepsis Diagnosis and Treatment
Canadian institutionsSt. Joseph’s Healthcare HamiltonMcMaster Children's HospitalHospital for Sick ChildrenMcMaster UniversityUniversity of Toronto
FundersCanadian Institutes of Health ResearchHamilton Health SciencesGroupe canadien de recherche en soins intensifsCanadian Child Health Clinician Scientist ProgramCanadian Blood ServicesMcMaster University
KeywordsSeptic shockRandomized controlled trialPilot trialMEDLINEEarly goal-directed therapyShock (circulatory)

Abstract

fetched live from OpenAlex

OBJECTIVE: The overall objective of our research is to determine in children with septic shock whether the use of a fluid-sparing strategy results in improved clinical outcomes without an increased risk of adverse events compared to usual care. The specific objective of this pilot randomized controlled trial was to evaluate the feasibility of a definitive multicenter trial to answer our research question. DESIGN: Pragmatic, 2-arm, parallel group, open-label, prospective pilot randomized controlled trial including a nested biosample-based translational study. SETTING: Pediatric tertiary care center. PATIENTS: Children aged 29 days to <18 years of age presenting to the emergency department or admitted to an inpatient ward (including the PICU) with suspected or confirmed septic shock and a need for ongoing resuscitation. INTERVENTIONS: Fluid-sparing vs. usual care resuscitation strategy continued until shock reversal. The fluid-sparing intervention comprised instructions to restrict fluid bolus therapy in conjunction with early initiation and/or preferential use of vasoactive medication support as a strategy to spare fluid while targeting the hemodynamic goals specified in the American College of Critical Care Medicine Surviving Sepsis Guidelines. The usual care strategy did not limit the use of fluid bolus therapy. MEASUREMENTS AND MAIN RESULTS: Fifty-three were randomized to usual care (n = 27) or fluid-sparing (n = 26). Fifty-one participants were available for primary outcome analysis. Primary feasibility outcomes related to participant enrollment and protocol adherence. Enrollment rate was 1.8 (51/29); 95% confidence interval [CI]: 1.3-2.3 participants/month. Study procedures were implemented in 49/51 (96.1%), 95% CI: 86.5-99.5% participants within 1 h of randomization in a median (interquartile range [IQR]) of 8 (5, 15) minutes. The protocol required the use of an exception to consent process and consent for ongoing participation was 48/51 (94.1%), 95% CI: 83.8-98.8%. There were no serious adverse events. CONCLUSIONS: We concluded the large multicenter SQUEEZE trial feasible to conduct. TRIAL REGISTRATION: ClinicalTrials.gov [NCT01973907]. Registered October 27, 2013, https://clinicaltrials.gov/study/NCT01973907 .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.007
Threshold uncertainty score0.024

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0030.007
Meta-epidemiology (narrow)0.0020.001
Meta-epidemiology (broad)0.0040.002
Bibliometrics0.0010.000
Science and technology studies0.0000.002
Scholarly communication0.0010.002
Open science0.0010.001
Research integrity0.0020.003
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.179
GPT teacher head0.409
Teacher spread0.230 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes2
Has abstractyes

Explore more

Same venuePilot and Feasibility StudiesSame topicSepsis Diagnosis and TreatmentFrench-language works237,207